NCT04212910Completed
Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model
Source: ClinicalTrials.gov · Last updated 23 Sept 2026
Brief summary (registry, in English)
Endometrial cancer (EC) is the most common gynecological malignancy in high-income countries. Prognosis and treatment are dictated by cancer histological subtype and grade coupled with surgical staging as described by Surgical International Federation of Gynecology and Obstetrics (FIGO) staging system. Surgery is the elective standard treatment and used for staging of EC. The purpose of this study is to collect images from a simultaneous PET/MRI study from which to extrapolate a preoperative, non-invasive, prognostic model.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 86 (actual)
- First submitted
- 24 Dec 2019
- Start date
- 23 Jul 2019
- Primary completion date
- 28 Feb 2025
- Lead sponsor
- IRCCS San Raffaele
- Diseases
- Endometrial cancer
- NCT number
- NCT04212910
What you commit to
- Study type: Observational
- Participants enrolled: 86
- From 23 Jul 2019 to the primary completion date, 28 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patients unsuitable for surgical intervention (comorbidity, contraindication or lack of consent, poor performance status)
Other illness
- any additional medical condition that may significantly interfere with study compliance
Age
- age \< 18 years, c) inability to complete the needed imaging examination (ie, severe claustrophobia)
Other
- all the contraindication for MRI (ie, pacemaker).
Who the study is looking for
- histopathological confirmation of a primary endometrial cancer
- age \> 18 years
- no contraindication to surgery (comorbidity, contraindication or lack of consent)
- no contraindication to preoperative imaging
- visible tumor at imaging
- signed inform consent.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Ospedale San Raffaele Coordinator of this site? Confirm its status | Milan | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.